Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Wonik IPS (240810) – Advance Notice of Financial Results / 2025-10-30 Semiconductors
  • [Disclosure] SK hynix (000660 / SKHY) – Provisional Financial Results (Fair Disclosure) / 2025-04-24 Semiconductors
  • [Disclosure] ISU PETASYS (007660) – Investor Relations (IR) Holding / 2026-02-20 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Market Measures on Stock Futures and Options / 2025-04-22 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – (Correction) Acquisition of Shares and Equity Securities of Other Corporations / 2025-12-22 Disclosures
  • [Research] Samsung Electronics (005930) – Mirae Asset Securities | HBM Price · Full-Stack Synergy · Shareholder Return / 2026-08-10 RESEARCH
  • [Disclosure] Hanwha Aerospace(012450) – Consolidated Provisional Financial Results / 2026-04-30 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – iM Hi Investment | Chinese Mobile Rebound · PC Restocking Potential · On-Device AI Spec Upgrades / 2024-01-05 RESEARCH

[Disclosure] Samsung Biologics (207940) – (Correction) Results of Measures Such as Prosecution Notice for Breach of Accounting Standards / 2025-02-04

Posted on February 4, 2025August 7, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Samsung Biologics has issued a correction disclosure following receipt of the written second-instance court judgment, amending the description of alleged violations from “No violations” to “Appeal dismissed (Not guilty)” and removing the note regarding pending judgment receipt.

📊 [Key Disclosure Details & Financial Figures]

  • Disclosure Title: (Correction) Results of Measures Such as Prosecution Notice for Breach of Accounting Standards
  • Original Filing Date: February 3, 2025
  • Reason for Correction: Amendments to disclosure details upon receipt of the written judgment
  • Key Correction Items:
    • Main Alleged Violations: (Before) No violations ➔ (After) Appeal dismissed (Not guilty)
    • Other Important Details: (Before) “The company has not yet received the written judgment and plans to issue a correction disclosure upon receipt.” ➔ (After) Deleted
  • Details of Measure Result (As Revised in Filing):
    • Result of Measure: Not guilty
    • Main Alleged Violations: Appeal dismissed (Not guilty)
    • Competent Court / Authority: Seoul High Court
    • Judgment / Decision Date: February 3, 2025 (Date of second-instance judgment rendering)
    • Date of Confirmation: February 3, 2025
  • Future Countermeasures: Taking necessary measures including enhancing accounting transparency and strengthening internal monitoring mechanisms
  • Other Important Details:
    • This disclosure is based on the second-instance ruling and is subject to change depending on potential Supreme Court appeals and rulings.
    • Subsequent progress and confirmed facts will be re-disclosed as they arise.
  • Related Disclosures:
    • July 12, 2018: Measures Such as Prosecution Notice for Breach of Accounting Standards
    • November 14, 2018: Measures Such as Prosecution Notice for Breach of Accounting Standards
    • September 04, 2020: Measures Such as Prosecution Notice for Breach of Accounting Standards
    • February 05, 2024: Results of Measures Such as Prosecution Notice for Breach of Accounting Standards
    • February 08, 2024: Results of Measures Such as Prosecution Notice for Breach of Accounting Standards
    • February 08, 2024: Measures Such as Prosecution Notice for Breach of Accounting Standards
    • February 03, 2025: Results of Measures Such as Prosecution Notice for Breach of Accounting Standards

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verifying Correction Upon Receipt of Written Judgment and Monitoring Potential Appeal

This correction disclosure provides notice that following the receipt of the written second-instance judgment from the Seoul High Court, the description of main alleged violations has been updated to ‘Appeal dismissed (Not guilty)’.

Checking potential future prosecution appeals and tracking subsequent official disclosures regarding legal developments is essential.

Relevant details can be verified in subsequent official disclosures and periodic filings.

📢 Disclaimer & Source Notice

Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s DART system.

Investment Risk Warning: This content is provided solely for informational and educational purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any security. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Samsung Biologics (207940) – Results of Measures Such as Prosecution Notice for Breach of Accounting Standards / 2025-02-03
Next Post: [Disclosure] ISU PETASYS (007660) – Advance Notice of Designation as Unfaithful Disclosure Company / 2025-02-04

Related Posts

  • [Disclosure] Hanwha Aerospace (012450) – Other Management Matters / 2025-09-01 Disclosures
  • [Disclosure] Hanwha Systems (272210) – (Corrected) Change in Revenue or Profit/Loss Structure Exceeding 30% (15% for Large Corporations) / 2024-02-23 Disclosures
  • [Disclosure] Celltrion (068270) – Change in Revenue or Profit/Loss Structure Exceeding 15% / 2025-02-25 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Results of Annual General Meeting of Shareholders / 2025-03-27 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Provisional Consolidated Earnings Results / 2024-01-25 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Provisional Financial Results (Fair Disclosure) / 2024-10-24 Semiconductors
  • [Disclosure] Celltrion (068270) – CHMP Positive Opinion Granted for CT-P39 (Xolair Biosimilar) by EMA / 2024-03-25 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Resolution on Calling of General Meeting of Shareholders / 2024-03-11 Bio & Healthcare
  • [Research] SK hynix (000660 / SKHY) – Shinhan | Supply Constraints · Memory Pricing · LTA / 2026-04-24 RESEARCH
  • [Disclosure] Hyundai Motor (005380) – Decision on Cash and In-Kind Dividend / 2024-04-25 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Investor Relations (IR) Holding (Notice) / 2025-05-13 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Decision on Cash and Goods Dividend / 2026-07-23 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Major Management Decisions Related to Investment Judgment / 2024-12-20 Semiconductors
  • [Disclosure] Hanwha Systems (272210) – Provisional Sales Results (Consolidated Financial Statements) / 2025-07-29 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme